Amid these challenges, Alphabet reported several positive developments. Waymo, the company's autonomous vehicle division, has expanded its paid robotaxi services to include highways in Los Angeles and ...
AbbVie is ending an eleven-year agreement with Alphabet’s Calico Labs, according to an internal email obtained by Stat News.
Critics, including some drugmakers, argue that new patent policies would make it more difficult for companies to bring ...
The alliance between AbbVie and Calico dates back to 2014, just a year after it was launched by Alphabet's Google unit, when ...
An 11-year, $2 billion partnership has yet to produce an approved drug, but five attempts are in clinical trials.
AbbVie and Calico first inked their partnership in 2014 with up to $1.5 billion in funding to advance therapies for diseases, ...
AbbVie (ABBV) is ending its partnership with Alphabet (GOOG) (GOOGL)-funded biotech company Calico Life Sciences after a decade, STAT’s Damian ...
AbbVie is ending a decade-long partnership with Calico Life Sciences, an Alphabet-funded biotech company focused on aging ...
AbbVie (ABBV) stock is in focus as the company ends its decade-long R&D deal with Calico, an Alphabet (GOOG)-backed startup ...
Mabwell (688062.SH), an innovation-driven biopharmaceutical company with entire industry chain, announced that its novel anti-IL-11 ...
A UK team claims to have cracked one of life's oldest mysteries - how to stop the body breaking down with age - and is now preparing human trials of a ‘Fountain of Youth' pill.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results